Page 21 - ARNM-3-3

Advances in Radiotherapy
& Nuclear Medicine Review of image-guided adaptive radiotherapy

adaptive radiotherapy for cervical cancer: Auto-contouring cancer. Radiother Oncol. 2022;175:144-151.
evaluation and dosimetric outcomes. Radiat Oncol.
2024;19(1):6. doi: 10.1016/j.radonc.2022.08.026
doi: 10.1186/s13014-024-02398-6 55. Lakomy DS, Yang, J, Vedam, S, et al. Clinical implementation
and initial experience with a 1.5 Tesla MR-Linac for
46. Moazzezi M, Rose B, Kisling K, Moore KL, Ray X. Prospects MR-guided radiation therapy for gynecologic cancer: An
for daily online adaptive radiotherapy via ethos for R-IDEAL Stage 1 and 2a first in humans feasibility study
prostate cancer patients without nodal involvement using of new technology implementation. Pract Radiat Oncol.
unedited CBCT auto-segmentation. J Appl Clin Med Phys. 2022;12(4):e296-e305.
2021;22(10):82-93.
doi: 10.1016/j.prro.2022.03.002
doi: 10.1002/acm2.13399
56. Fast M, van de Schoot A, van de Lindt T, Carbaat C, van
47. De Jong R, Visser J, van Wieringen N, Wiersma J, Geijsen D,
Bel A. Feasibility of Conebeam CT-based online adaptive der Heide U, Sonke JJ. Tumor trailing for liver SBRT on the
radiotherapy for neoadjuvant treatment of rectal cancer. MR-linac. Int J Radiat Oncol Biol Phys. 2019;103(2):468-478.
Radiat Oncol. 2021;16(1):136. doi: 10.1016/j.ijrobp.2018.09.011
doi: 10.1186/s13014-021-01866-7 57. Hunt A, Hansen VN, Oelfke U, Nill S, Hafeez S. Adaptive
48. Møller DS, Holt MI, Alber M, et al. Adaptive radiotherapy radiotherapy enabled by MRI guidance. Clin Oncol (R Coll
for advanced lung cancer ensures target coverage and Radiol). 2018;30(11):711-719.
decreases lung dose. Radiother Oncol. 2016;121(1):32-38. doi: 10.1016/j.clon.2018.08.001
doi: 10.1016/j.radonc.2016.08.019 58. Parikh PJ, Lee P, Low DA, et al. A Multi-institutional phase 2
49. Wang G, Wang Z, Zhang Y, et al. Daily online adaptive trial of ablative 5-fraction stereotactic magnetic resonance-
radiation therapy of postoperative endometrial and cervical guided on-table adaptive radiation therapy for borderline
cancer with PTV margin reduction to 5 mm: Dosimetric resectable and locally advanced pancreatic cancer. Int J
outcomes, acute toxicity, and first clinical experience. Adv Radiat Oncol Biol Phys. 2023;117(4):799-808.
Radiat Oncol. 2024;9(7):101510.
doi: 10.1016/j.ijrobp.2023.05.023
doi: 10.1016/j.adro.2024.101510
59. Weisz Ejlsmark M, Bahij R, Schytte T, et al. Adaptive MRI-
50. Branco D, Mayadev J, Moore K, Ray X. Dosimetric and guided stereotactic body radiation therapy for locally
feasibility evaluation of a CBCT-based daily adaptive advanced pancreatic cancer - A phase II study. Radiother
radiotherapy protocol for locally advanced cervical cancer. Oncol. 2024;197:110347.
J Appl Clin Med Phys. 2023;24(1):e13783.
doi: 10.1016/j.radonc.2024.110347
doi: 10.1002/acm2.13783
51. Yock AD, Ahmed M, Ayala-Peacock D, Chakravarthy AB, 60. Song Y, Zhang Y, Wang H, et al. Case report: MR-LINAC-
Price M. Initial analysis of the dosimetric benefit and clinical guided adaptive radiotherapy for gastric cancer. Front Oncol.
resource cost of CBCT-based online adaptive radiotherapy 2023;13:1159197.
for patients with cancers of the cervix or rectum. J Appl Clin doi: 10.3389/fonc.2023.1159197
Med Phys. 2021;22(10):210-221.
61. Angelov L, Mohammadi AM, Bennett EE, et al. Impact of
doi: 10.1002/acm2.13425 2-staged stereotactic radiosurgery for treatment of brain
52. Morrow NV, Lawton CA, Qi XS, Li XA. Impact of computed metastases ≥2 cm. J Neurosurg. 2018;129(2):366-382.
tomography image quality on image-guided radiation doi: 10.3171/2017.3.JNS162532
therapy based on soft tissue registration. Int J Radiat Oncol
Biol Phys. 2012;82(5):e733-e738. 62. Higuchi Y, Serizawa T, Nagano O, et al. Three-staged
stereotactic radiotherapy without whole brain irradiation
doi: 10.1016/j.ijrobp.2011.11.043
for large metastatic brain tumors. Int J Radiat Oncol Biol
53. Ramella S, Fiore M, Silipigni S, et al. Local control and Phys. 2009;74(5):1543-1548.
toxicity of adaptive radiotherapy using weekly CT imaging:
Results from the LARTIA trial in Stage III NSCLC. J Thorac doi: 10.1016/j.ijrobp.2008.10.035
Oncol. 2017;12(7):1122-1130. 63. Wu J, Lu AD, Zhang LP, Zuo YX, Jia YP. Study of clinical
doi: 10.1016/j.jtho.2017.03.025 outcome and prognosis in pediatric core binding factor-
acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi.
54. Schiff JP, Price AT, Stowe HB, et al. Simulated computed 2019;40(1):52-57.
tomography-guided stereotactic adaptive radiotherapy
(CT-STAR) for the treatment of locally advanced pancreatic doi: 10.3760/cma.j.issn.0253-2727.2019.01.010

Volume 3 Issue 3 (2025) 13 doi: 10.36922/ARNM025110012